Harbour BioMed, a global biopharmaceutical company, and Evinova, a global health-tech company, have entered a strategic ...

The U.S. Food and Drug Administration approved Johnson & Johnson’s drug Darzalex Faspro as the first treatment for adults with high-risk smoldering multiple myeloma, a precursor to the blood cancer.

Argonaut Manufacturing Services, a contract development manufacturing organization (CDMO) specializing in aseptic drug product manufacturing and the manufacturing of life science and diagnostic ...

Cytiva has launched the fibro dT platform for mRNA capture and purification processes.

Alvotech and Advanz Pharma Receive Marketing Authorizations for Gobivaz, a Biosimilar to Simponi (golimumab), from the MHRA.

Abzena, an integrated CDMO for complex biologics and bioconjugates, and Mabqi, a biotechnology company focused on developing fully human antibodies, formed a strategic partnership.

Biovectra and Revolution Biomanufacturing have announced a collaboration that grants Biovectra access to Revolution Biomanufacturing's proprietary platforms to enhance mRNA stability and translational ...

Touchlight has expanded its mbDNA platform with the introduction of three new circular DNA architectures: sscDNA, hsscDNA, and dscDNA.

The research collaboration agreement will offer new chemical entity (NCE)-eligible pro-drug candidates to people affected by blinding eye conditions.

Optimer binders against three therapeutic targets to support drug validation and potential clinical trial applications ...

Agreement includes approximately $350 million in cash and upfront technology license fees for Evotec’s continuous manufacturing platform.

Simtra BioPharma Solutions is advancing a dual-continent expansion aimed at boosting capacity for sterile injectable drugs.